What is the Relationship Between Low-Grade Inflammation and Insulin Resistance?



Low-grade inflammation is a chronic state of mild inflammation that can affect various tissues and organs, especially in conditions such as obesity, type 2 diabetes and metabolic syndrome. Low-grade inflammation may contribute to the development of insulin resistance, a condition in which the body's cells do not respond properly to the hormone insulin, leading to impaired glucose metabolism and increased risk of cardiovascular disease and Alzheimer's disease.

The relationship between low-grade inflammation and insulin resistance is complex and involves multiple mechanisms. Some of the possible mechanisms are:

- Overnutrition and lipid accumulation in adipocytes (fat cells) can trigger the release of inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6) and C-reactive protein (CRP), from adipose tissue and immune cells. These cytokines can interfere with insulin signaling and action in various target tissues, such as muscle, liver and brain, by activating inflammatory pathways, such as nuclear factor-kappa B (NF-κB), c-Jun N-terminal kinase (JNK) and inhibitor of kappa B kinase beta (IKKβ)  .

- Inflammation can also impair the function of the pancreatic beta cells, which produce and secrete insulin. Inflammatory cytokines can induce oxidative stress, endoplasmic reticulum stress and apoptosis (cell death) in beta cells, reducing their insulin secretion capacity and worsening glucose homeostasis.

- Inflammation can affect the blood-brain barrier (BBB), which regulates the exchange of substances between the blood and the brain. Inflammatory cytokines can increase the permeability of the BBB, allowing the entry of harmful molecules into the brain. This can cause neuroinflammation, oxidative stress and neuronal damage, which can impair cognitive function and increase the risk of Alzheimer's disease. Inflammation can also reduce the expression of insulin receptors and insulin-like growth factor-1 (IGF-1) receptors in the brain, affecting neuronal survival, plasticity and memory formation.

Therefore, low-grade inflammation is a potential link between metabolic disorders and neurodegenerative diseases, and a possible target for prevention and treatment strategies.


References:

: de Rooij SR et al. Low-Grade Chronic Inflammation in the Relationship between Insulin Sensitivity and Cardiovascular Disease (RISC) Population: Associations with insulin resistance and cardiometabolic risk profile. Diabetes Care 2009;32(7):1295–1301. https://doi.org/10.2337/dc08-1795

: Vinuesa A et al. Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer’s Disease. Front Neurosci 2021;15:653651. https://doi.org/10.3389/fnins.2021.653651

: Donath MY et al. Mechanisms of beta-cell death in type 2 diabetes. Diabetes 2005;54 Suppl 2:S108–S113. https://doi.org/10.2337/diabetes.54.suppl_2.s108

: Craft S et al. The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Arch Neurol 2009;66(3):300–305. https://doi.org/10.1001/archneurol.2009.27

Comments